X

Mental Health & Addiction (MHA) Community

Mental illness and addiction affect at least 1 in 5 adults in the US and represent a substantial burden to individuals and their family as well as to society. The goal of this Community is to increase awareness in topics relevant to the pharmacological treatment of mental health and addiction, increase diversity in the society by attracting new members, and inspire our current members to think more critically about developing research towards understanding the etiology, targeting novel therapeutic approaches, and personalized therapy for these debilitating illnesses.
Please check back for more announcements and events from the Mental Health & Addiction Community.

Kristin Bigos, PhD

Community Chair

 

Vijay Ramchandani, PhD

Community Vice Chair

 

Balmiki Ray, MD

Community Vice Chair

 

Photo Gallery
Recent News
  • A Unique Collection of State-of-the-Art Pharmacometric and Systems Pharmacology Approaches in Rare Diseases Pharmacology and Therapeutics
    November 16, 2018
  • New Board Members Appointed
    November 15, 2018
  • ASCPT Members-Only Webinar Presented by the Pharmacogenomics Community (PGx)
    November 14, 2018
Contact Us